Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 1

A fatal Acremonium falciforme peritonitis

Pages
222–224
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This indicates that more antifungal susceptibility studies should be done before making a comment about in vivo and in vitro concordance of susceptibility of filamentous fungi.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A case of Acremonium falciforme peritonitis in a 50-year-old man with a 10-year history of end stage renal disease that was on Continuous Ambulatory Peritoneal Dialysis for 8 years is reported.
📊
Key Findings & Data:In vitro fluconazole and amphotericin B minimum inhibitory concentrations (MICs) were found as 6 and 0.125 µg/mL respectively.
💡
Conclusion & Impact:This indicates that more antifungal susceptibility studies should be done before making a comment about in vivo and in vitro concordance of susceptibility of filamentous fungi.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

A case of Acremonium falciforme peritonitis in a 50-year-old man with a 10-year history of end stage renal disease that was on Continuous Ambulatory Peritoneal Dialysis for 8 years is reported. The aim of this report is to remind the clinician that in resistant and life-threatening peritonitis, A. falciforme may be the cause. This fungus was identified as A. falciforme in culture by its characteristic colonies and microscopic morphological findings. In vitro fluconazole and amphotericin B minimum inhibitory concentrations (MICs) were found as 6 and 0.125 µg/mL respectively. First fluconazole and then amphotericin B was administered, but patient was deceased on day 10 of amphotericin B therapy. This indicates that more antifungal susceptibility studies should be done before making a comment about in vivo and in vitro concordance of susceptibility of filamentous fungi.

🔖

Cite This Article

ALTINTOP, Y. A., KOÇ, A. N. (2018). A fatal Acremonium falciforme peritonitis. Medicine Science, Cilt: 7 - Sayı: 1, 222–224. https://ajindex.com/articles/277224

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Lau YL, Yuen KY, Lee CW, Chan CF. Invasive Acremonium falciforme infection in a patient with severe combined immunodeficiency. Clin Infect Dis. 1995;20(1):197–8.
  2. Summerbell RC, Gueidan C, Schroers H-J, de Hoog GS, Starink M, Rosete YA, Guarro J, Scott JA. Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium. Stud Mycol. 2011;68:139–62.
  3. Nedret Koç A, Erdem F, Patiroğlu T. Case Report. Acremonium falciforme fungemia in a patient with acute leukaemia. Mycoses. 2002;45(5-6):202–3.
  4. Guarro J, Gams W, Pujol I, Gene J. Acremonium species: new emerging fungal opportunists--in vitro antifungal susceptibilities and review. Clin Infect Dis. 1997;25(5):1222–9.
  5. Rotowa NA, Shadomy HJ, Shadomy S. In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens. Mycoses. 1990;33(4):203–11.
  6. Fincher RM, Fisher JF, Lovell RD, Newman CL, Espinel-Ingroff A, Shadomy HJ. Infection due to the fungus acremonium (Cephalosporium). Medicine. 1991;70(6):398–409.
  7. Fakharian A, Dorudinia A, Alavi Darazam I, Mansouri D, Masjedi MR. Acremonium Pneumonia: Case Report and Literature Review. Tanaffos. 2015;14(2):156–60.
  8. Tuon FF, Pozzi C, Penteado-filho SR, Benvenutti R. Case Report / Relato de Caso Recurrent Acremonium infection in a kidney transplant patient treated with voriconazole: a case report Infecção recidivante por Acremonium em paciente transplantado renal tratado com voriconazol: relato de caso. 2010;43(4):467–8.